About 2% of cases of diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBCL) with MYC and BCL2 rearrangements show expression of terminal deoxynucleotidyl transferase (TdT) (1). This evidence concerns the gene DNTT and B-cell non-Hodgkin lymphoma.